Multifunctional cerium nanolabels in electrochemical immunosensing with improved robustness and performance: determination of TIM-1 in colorectal cancer scenarios as a case study.
Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Andrea Cabrero-MartínDepartamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid, Pza. de Las Ciencias 2, 28040, Madrid, Spain.ORCID 0009-0001-0785-1495
Sara SantiagoDepartamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid, Pza. de Las Ciencias 2, 28040, Madrid, Spain.ORCID 0000-0002-1206-1455
Verónica SerafínDepartamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid, Pza. de Las Ciencias 2, 28040, Madrid, Spain.ORCID 0000-0003-0034-8456
María PedreroDepartamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid, Pza. de Las Ciencias 2, 28040, Madrid, Spain.ORCID 0000-0002-2047-396X
Ana Montero-CalleChronic Disease Programme, UFIEC, Institute of Health Carlos III, Majadahonda, 28220, Madrid, Spain.ORCID 0000-0001-5141-0454
José M PingarrónDepartamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid, Pza. de Las Ciencias 2, 28040, Madrid, Spain.ORCID 0000-0003-2271-1383
Rodrigo BarderasChronic Disease Programme, UFIEC, Institute of Health Carlos III, Majadahonda, 28220, Madrid, Spain. r.barderasm@isciii.es.ORCID 0000-0003-3539-7469
Susana CampuzanoDepartamento de Química Analítica, Facultad de CC. Químicas, Universidad Complutense de Madrid, Pza. de Las Ciencias 2, 28040, Madrid, Spain. susanacr@quim.ucm.es.ORCID 0000-0002-9928-6613
Funding
AES-ISCIII PI20CIII/00019Ministerio de Ciencia e Innovación JDC2022-048757-IMinisterio de Ciencia e Innovación PID2022-136351OB-I00Ministerio de Ciencia e Innovación PID2022-140307OB-I00Ministerio de Ciencia e Innovación PREP2022-000170
6 · The paper itself
Abstract
A multifunctional cerium oxide nanoparticles (CeO
Indexed as
Biosensing TechniquesCeriumColorectal NeoplasmsElectrochemical TechniquesHepatitis A Virus Cellular Receptor 1Metal NanoparticlesNanoparticlesAntibodies, ImmobilizedBiomarkers, TumorHumansImmunoassayLimit of DetectionAntibodies, ImmobilizedBiomarkers, Tumorceric oxideCeriumHAVCR1 protein, humanHepatitis A Virus Cellular Receptor 1CeO2 multifunctional nanolabelsColorectal cancerElectrochemical immunoplatformsNanocarriersNanozymesTIM-1
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Multifunctional cerium nanolabels in electrochemical immunosensing with improved robustness and performance: determination of TIM-1 in colorectal cancer scenarios as a case study. · full record | OpenQuestion